FAM-TRASTUZUMAB DERUXTECAN-NXKI for Breast cancer metastatic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,774 adverse event reports in the FDA FAERS database where FAM-TRASTUZUMAB DERUXTECAN-NXKI was used for Breast cancer metastatic.
Most Reported Side Effects for FAM-TRASTUZUMAB DERUXTECAN-NXKI
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 1,037 | 13.8% | 129 | 270 |
| Interstitial lung disease | 880 | 11.7% | 280 | 355 |
| Disease progression | 794 | 10.6% | 432 | 263 |
| Death | 717 | 9.5% | 717 | 73 |
| Fatigue | 652 | 8.7% | 32 | 86 |
| Off label use | 651 | 8.7% | 123 | 112 |
| Vomiting | 464 | 6.2% | 71 | 175 |
| Diarrhoea | 463 | 6.2% | 65 | 194 |
| Pneumonitis | 337 | 4.5% | 100 | 131 |
| No adverse event | 315 | 4.2% | 0 | 0 |
| Decreased appetite | 301 | 4.0% | 71 | 133 |
| Alopecia | 282 | 3.8% | 19 | 39 |
| Asthenia | 250 | 3.3% | 22 | 76 |
| Dyspnoea | 235 | 3.1% | 63 | 101 |
| Intentional product use issue | 234 | 3.1% | 21 | 62 |
Other Indications for FAM-TRASTUZUMAB DERUXTECAN-NXKI
Her2 positive breast cancer (1,578)
Product used for unknown indication (1,349)
Breast cancer (1,059)
Her2 low breast cancer (643)
Her2 positive gastric cancer (353)
Her2 negative breast cancer (220)
Gastric cancer (179)
Breast cancer female (157)
Her2 mutant non-small cell lung cancer (101)
Non-small cell lung cancer (87)
Other Drugs Used for Breast cancer metastatic
PALBOCICLIB (18,160)
RIBOCICLIB (9,771)
LETROZOLE (6,856)
TRASTUZUMAB (6,303)
FULVESTRANT (4,570)
PERTUZUMAB (3,784)
CAPECITABINE (3,691)
PACLITAXEL (3,241)
DOCETAXEL (3,070)
EVEROLIMUS (2,751)